The U.S. Food and Drug Administration said on Wednesday that it has approved Bayer's drug for patients with a form of lung ...

The U.S. Food and Drug Administration on Wednesday said it has approved Bayer's drug for patients with a type of lung cancer ...

“The biggest risk for lung cancer is cigarette smoking,” says Waqar. It’s estimated that 85% of lung cancer deaths are ...

Humphrey traveled from Michigan to Chicago to seek a second opinion at Northwestern Medicine in May 2024. A bronchoscopy ...

Lung cancer is not a smoker’s disease anymore. It is a breather’s disease, driven by toxic air and environmental exposures.

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

Cellular therapies, including TIL, TCR, and CAR-T, are transforming lung cancer care by utilizing personalized immune cells ...

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...